Everything about Dasatinib
Kantarjian et al53 assessed the efficacy and safety of dasatinib, as in comparison with imatinib, for the first-line treatment method of CML-CP. 5 hundred and nineteen individuals with recently diagnosed CML-CP were randomly assigned to obtain dasatinib in a dose of a hundred mg when everyday (259 clients) or imatinib at a dose of 400 mg after dail